| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $4.8M | +134.2% |
| SG&A Expense | $7.3M | +3423.6% |
| Income Tax | $0 | — |
| Net Income | -$12.1M | +5.1% |
| EPS (Basic) | -$1.12 | +24.8% |
| EPS (Diluted) | -$1.12 | +24.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Total Assets | $9.4M | -29.3% |
| Current Liabilities | $2.1M | +144.3% |
| Total Liabilities | $2.1M | +144.3% |
| Stockholders' Equity | $7.3M | -41.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.5M | -50.4% |
| Financing Cash Flow | $3.7M | -75.0% |